Search

Bruce F Bell

Examiner (ID: 11075)

Most Active Art Unit
1741
Art Unit(s)
1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102
Total Applications
2788
Issued Applications
2338
Pending Applications
153
Abandoned Applications
297

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7449237 [patent_doc_number] => 20040067531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Methods of modulating protein tyrosine kinase function with substituted indolinone compounds' [patent_app_type] => new [patent_app_number] => 10/458730 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43570 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067531.pdf [firstpage_image] =>[orig_patent_app_number] => 10458730 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/458730
Methods of modulating protein tyrosine kinase function with substituted indolinone compounds Jun 10, 2003 Abandoned
Array ( [id] => 7437198 [patent_doc_number] => 20040002524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Benzimidazole compounds and their use as estrogen agonists/antagonists' [patent_app_type] => new [patent_app_number] => 10/460565 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35788 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002524.pdf [firstpage_image] =>[orig_patent_app_number] => 10460565 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/460565
Benzimidazole compounds and their use as estrogen agonists/antagonists Jun 10, 2003 Abandoned
Array ( [id] => 7403209 [patent_doc_number] => 20040019219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'N-alkylated thiazolium salts and process for their preparation' [patent_app_type] => new [patent_app_number] => 10/458092 [patent_app_country] => US [patent_app_date] => 2003-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4784 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019219.pdf [firstpage_image] =>[orig_patent_app_number] => 10458092 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/458092
N-alkylated thiazolium salts and process for their preparation Jun 9, 2003 Abandoned
Array ( [id] => 5808363 [patent_doc_number] => 20060094718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'O-substituted hydroxyaryl derivatives' [patent_app_type] => utility [patent_app_number] => 10/515622 [patent_app_country] => US [patent_app_date] => 2003-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59375 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094718.pdf [firstpage_image] =>[orig_patent_app_number] => 10515622 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/515622
O-substituted hydroxyaryl derivatives Jun 4, 2003 Issued
Array ( [id] => 7398597 [patent_doc_number] => 20040039037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Heterocyclic compounds and uses thereof' [patent_app_type] => new [patent_app_number] => 10/455149 [patent_app_country] => US [patent_app_date] => 2003-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8418 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20040039037.pdf [firstpage_image] =>[orig_patent_app_number] => 10455149 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/455149
Heterocyclic compounds and uses thereof Jun 3, 2003 Issued
Array ( [id] => 7314660 [patent_doc_number] => 20040034078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Benzimidazole inhibitors of poly(ADP-ribosyl) polymerase' [patent_app_type] => new [patent_app_number] => 10/453973 [patent_app_country] => US [patent_app_date] => 2003-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22723 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034078.pdf [firstpage_image] =>[orig_patent_app_number] => 10453973 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/453973
Benzimidazole inhibitors of poly(ADP-ribosyl) polymerase Jun 3, 2003 Abandoned
Array ( [id] => 1206412 [patent_doc_number] => 06716993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-06 [patent_title] => 'Polymethine compound and near-infrared absorbing material comprising same' [patent_app_type] => B2 [patent_app_number] => 10/453514 [patent_app_country] => US [patent_app_date] => 2003-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6204 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716993.pdf [firstpage_image] =>[orig_patent_app_number] => 10453514 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/453514
Polymethine compound and near-infrared absorbing material comprising same Jun 3, 2003 Issued
Array ( [id] => 1197000 [patent_doc_number] => 06727246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-27 [patent_title] => '1-(aminoalkyl)-3-sulfonylindole-and-indazole derivatives as 5-hydroxytryptamine-6 ligands' [patent_app_type] => B2 [patent_app_number] => 10/453009 [patent_app_country] => US [patent_app_date] => 2003-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9575 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 548 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727246.pdf [firstpage_image] =>[orig_patent_app_number] => 10453009 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/453009
1-(aminoalkyl)-3-sulfonylindole-and-indazole derivatives as 5-hydroxytryptamine-6 ligands Jun 2, 2003 Issued
Array ( [id] => 6825788 [patent_doc_number] => 20030236410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Pharmaceutical composition containing bicyclic type compounds' [patent_app_type] => new [patent_app_number] => 10/452349 [patent_app_country] => US [patent_app_date] => 2003-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8376 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236410.pdf [firstpage_image] =>[orig_patent_app_number] => 10452349 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/452349
Pharmaceutical composition containing bicyclic type compounds Jun 1, 2003 Abandoned
Array ( [id] => 720321 [patent_doc_number] => 07049333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis' [patent_app_type] => utility [patent_app_number] => 10/448851 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18887 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 544 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049333.pdf [firstpage_image] =>[orig_patent_app_number] => 10448851 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/448851
Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis May 29, 2003 Issued
Array ( [id] => 892328 [patent_doc_number] => 07345078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'NF-κB inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/449662 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 27048 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345078.pdf [firstpage_image] =>[orig_patent_app_number] => 10449662 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/449662
NF-κB inhibitors and uses thereof May 29, 2003 Issued
Array ( [id] => 7251808 [patent_doc_number] => 20050272936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Imidazolium cxcr3 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/516970 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5571 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272936.pdf [firstpage_image] =>[orig_patent_app_number] => 10516970 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/516970
Imidazolium cxcr3 inhibitors May 28, 2003 Abandoned
Array ( [id] => 6664627 [patent_doc_number] => 20030203953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Repinotan kit' [patent_app_type] => new [patent_app_number] => 10/444820 [patent_app_country] => US [patent_app_date] => 2003-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4589 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203953.pdf [firstpage_image] =>[orig_patent_app_number] => 10444820 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/444820
Repinotan kit May 21, 2003 Abandoned
Array ( [id] => 5643343 [patent_doc_number] => 20060281798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Methods of using thiazolidinedithione derivatives' [patent_app_type] => utility [patent_app_number] => 10/515087 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20392 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281798.pdf [firstpage_image] =>[orig_patent_app_number] => 10515087 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/515087
Methods of using thiazolidinedithione derivatives May 15, 2003 Abandoned
Array ( [id] => 7605160 [patent_doc_number] => 07115769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Synthesis of 2-alkylcysteine via phase transfer catalysis' [patent_app_type] => utility [patent_app_number] => 10/438757 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6488 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115769.pdf [firstpage_image] =>[orig_patent_app_number] => 10438757 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/438757
Synthesis of 2-alkylcysteine via phase transfer catalysis May 14, 2003 Issued
Array ( [id] => 7387048 [patent_doc_number] => 20040082639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders' [patent_app_type] => new [patent_app_number] => 10/438152 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 93216 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 44 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082639.pdf [firstpage_image] =>[orig_patent_app_number] => 10438152 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/438152
N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders May 13, 2003 Issued
Array ( [id] => 1113172 [patent_doc_number] => 06803381 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-12 [patent_title] => 'Carbamic acid derivatives' [patent_app_type] => B1 [patent_app_number] => 10/438361 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8929 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/803/06803381.pdf [firstpage_image] =>[orig_patent_app_number] => 10438361 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/438361
Carbamic acid derivatives May 13, 2003 Issued
Array ( [id] => 6926551 [patent_doc_number] => 20050239808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur' [patent_app_type] => utility [patent_app_number] => 10/514015 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12143 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239808.pdf [firstpage_image] =>[orig_patent_app_number] => 10514015 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/514015
Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur May 8, 2003 Abandoned
Array ( [id] => 741688 [patent_doc_number] => 07030144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Substituted imidazole derivatives: GABAA receptor ligands' [patent_app_type] => utility [patent_app_number] => 10/429056 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15578 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030144.pdf [firstpage_image] =>[orig_patent_app_number] => 10429056 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/429056
Substituted imidazole derivatives: GABAA receptor ligands May 1, 2003 Issued
Array ( [id] => 7402160 [patent_doc_number] => 20040019093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them' [patent_app_type] => new [patent_app_number] => 10/425210 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4507 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019093.pdf [firstpage_image] =>[orig_patent_app_number] => 10425210 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/425210
Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them Apr 28, 2003 Abandoned
Menu